Content area
Full Text
IBSchek is a blood test marketed to assist in the diagnosis of irritable bowel syndrome with predominant diarrhea (IBS-D) or with mixed bowel habits (IBS-M) in adults.
| Test | Indication | Population | Cost* |
|---|---|---|---|
| IBSchek | Diagnosis of IBS-D or IBS-M | Adults suspected of having IBS-D or IBS-M | $199 |
IBS-D = irritable bowel syndrome with predominant diarrhea; IBS-M = irritable bowel syndrome with mixed bowel habits.
*—Payment rate according to Commonwealth Diagnostics International.
Accuracy
The diagnosis of IBS-D or IBS-M is made using Rome IV criteria, which include the presence of certain symptoms, the absence of alarm symptoms, and negative screening blood test results (complete blood count, C-reactive protein, fecal calprotectin, and celiac serologies).1,2 The type of IBS is categorized based on the predominant type of stool using the Bristol stool scale: IBS-D, IBS with predominant constipation, IBS-M, and IBS unclassified.